Clinical Trials › NCT05767736
Active, Not Recruiting
A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)
Sponsored by Biogen
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 10500
Target enrollment
1
U.S. states
Jun 2024
Start date
Dec 2032
Expected completion
Interventions / Treatments
Diroximel FumarateDimethyl FumarateDisease-Modifying Therapies (DMTs)
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Massachusetts1 site
Cambridge
MS centers in Massachusetts
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Massachusetts centersCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
